Synaptogenix Inc (SNPX)

[Cyosol]

Unfortunate for them maybe. For us this is good news because it further confirms what Dr. Alkon has been saying all along. Just read the articles in my stickied post and you'll find countless examples of how PKC epsilon is the bullseye we should be targeting rather than the Ab/Tau byproducts BP has been going after unsuccessfully all these years (which by the way are eliminated by activating PKC epsilon, according to the articles).

Hopefully BP will soon discover what Neurotrope is doing and cancel all their AD programs, knowing that their billions are better spent investing in this company rather than keep pursuing their usual outdated approach that has never ever worked.